Sujal Shah, Chief Executive Officer at CymaBay Therapeutics, Inc. (CBAY), bought 5,000 shares at $9.90 ($50K) on 2018-10-15, disclosed to the SEC on 2018-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CBAY | SELL | 2023-10-10 | $1.8M | — | Filing → |
| CBAY | BUY | 2022-06-07 | $200K | — | Filing → |
| CBAY | BUY | 2019-10-15 | $22K | — | Filing → |